SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 27 | 26 | −1 |
| Shares | 1.73M | 1.69M | −44.0K (−2.5%) |
| Value | $9.59M | $11.3M | +$1.69M (+17.7%) |
New holders (4)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prelude Capital Management, LLC | 31,125 | $208.0K | 0.01% |
| Citigroup Inc | 1,918 | $13.0K | 0.00% |
| Cutler Group LP | 2,000 | $13.0K | 0.00% |
| Global Retirement Partners, LLC | 1,000 | $3.00K | 0.00% |
Sold out (5)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Virtu Financial LLC | 13,935 | $77.0K |
| Gsa Capital Partners LLP | 10,447 | $58.0K |
| Group One Trading, L.P. | 5,578 | $31.0K |
| The PNC Financial Services Group, Inc. | 704 | $4.00K |
| Amplius Wealth Advisors, LLC | 5 | $0 |